| Mabel Jansma, | |
|
11001 W 120th Ave Ste 310, Broomfield, CO 80021-3493 | |
| (888) 265-2680 | |
| Not Available |
| Full Name | Mabel Jansma |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 11001 W 120th Ave Ste 310, Broomfield, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295244960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mabel Jansma, 11001 W 120th Ave Ste 310, Broomfield, CO 80021-3493 Ph: () - | Mabel Jansma, 11001 W 120th Ave Ste 310, Broomfield, CO 80021-3493 Ph: (888) 265-2680 |
News Archive
Premature aging in people with HIV is now recognized as a new, significant public health challenge. Accumulating evidence shows that people with HIV who are between 45 to 60 years old develop characteristics typically observed in people without HIV that are more than 70 years of age.
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. A report on the study, published online and in an upcoming issue of Annals of Neurology, raises questions about whether some generic products are safe and effective when a narrow dose range separates patients from help and harm.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID)'s Vaccine Research Center (VRC) and the University of Washington School of Medicine's Institute for Protein Design (IPD) developed a universal flu vaccine candidate using small particles (nanoparticles), which can induce a long-lasting immune response.
Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the effects of STX209 on social impairment in adolescents and adults with fragile X syndrome.
› Verified 2 days ago
Lauren Kaye Braaten, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8401 Arista Pl, Broomfield, CO 80021 Phone: 720-777-1330 | |
Erica Applegate, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8401 Arista Pl, Broomfield, CO 80021 Phone: 720-777-9183 | |
Ryan Edward Burns, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3305 W 144th Ave Unit 200, Broomfield, CO 80023 Phone: 303-284-6569 | |
Patrice S Lensmire Gauthier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12970 Sheridan Blvd, Broomfield, CO 80020 Phone: 303-785-5800 | |
Erica R Mercer, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 12975 Sheridan Blvd, Broomfield, CO 80020 Phone: 303-785-5800 | |
Northbrook Hand Therapy, Inc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Garden Ctr, Bldg A, Ste 104, Broomfield, CO 80020 Phone: 720-887-3637 Fax: 720-887-3634 | |
Katherine Krumm Erley, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 E 13th Ave, Broomfield, CO 80020 Phone: 303-466-6308 |